AU2003905084A0 - Cephem Compounds - Google Patents

Cephem Compounds

Info

Publication number
AU2003905084A0
AU2003905084A0 AU2003905084A AU2003905084A AU2003905084A0 AU 2003905084 A0 AU2003905084 A0 AU 2003905084A0 AU 2003905084 A AU2003905084 A AU 2003905084A AU 2003905084 A AU2003905084 A AU 2003905084A AU 2003905084 A0 AU2003905084 A0 AU 2003905084A0
Authority
AU
Australia
Prior art keywords
cephem compounds
cephem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003905084A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Fujisawa Pharmaceutical Co Ltd
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd, Fujisawa Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Publication of AU2003905084A0 publication Critical patent/AU2003905084A0/en
Priority to ES04773402T priority Critical patent/ES2340928T3/en
Priority to JP2006526812A priority patent/JP4643577B2/en
Priority to DE602004026451T priority patent/DE602004026451D1/en
Priority to CA002536636A priority patent/CA2536636A1/en
Priority to EP04773402A priority patent/EP1663245B1/en
Priority to AT04773402T priority patent/ATE463248T1/en
Priority to KR1020067003919A priority patent/KR20060069475A/en
Priority to PCT/JP2004/014018 priority patent/WO2005027909A1/en
Priority to TW093128132A priority patent/TW200524943A/en
Priority to CNA2004800269008A priority patent/CN1852715A/en
Priority to US10/942,916 priority patent/US7192943B2/en
Priority to ARP040103366A priority patent/AR045768A1/en
Priority to MXPA06003068A priority patent/MXPA06003068A/en
Abandoned legal-status Critical Current

Links

AU2003905084A 2003-09-18 2003-09-18 Cephem Compounds Abandoned AU2003905084A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
MXPA06003068A MXPA06003068A (en) 2003-09-18 2004-09-17 Cephem compounds.
KR1020067003919A KR20060069475A (en) 2003-09-18 2004-09-17 Cephem compounds
PCT/JP2004/014018 WO2005027909A1 (en) 2003-09-18 2004-09-17 Cephem compounds
DE602004026451T DE602004026451D1 (en) 2003-09-18 2004-09-17 Cephem CONNECTIONS
CA002536636A CA2536636A1 (en) 2003-09-18 2004-09-17 Cephem compounds
EP04773402A EP1663245B1 (en) 2003-09-18 2004-09-17 Cephem compounds
AT04773402T ATE463248T1 (en) 2003-09-18 2004-09-17 CEPHEM COMPOUNDS
ES04773402T ES2340928T3 (en) 2003-09-18 2004-09-17 CEFEM COMPOUNDS.
JP2006526812A JP4643577B2 (en) 2003-09-18 2004-09-17 Cephem compound
TW093128132A TW200524943A (en) 2003-09-18 2004-09-17 Cephem compounds
CNA2004800269008A CN1852715A (en) 2003-09-18 2004-09-17 Cephem compounds
US10/942,916 US7192943B2 (en) 2003-09-18 2004-09-17 Cephem compounds
ARP040103366A AR045768A1 (en) 2003-09-18 2004-09-17 CEFEM COMPOUNDS AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS

Publications (1)

Publication Number Publication Date
AU2003905084A0 true AU2003905084A0 (en) 2003-10-02

Family

ID=

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US10420841B2 (en) 2013-03-15 2019-09-24 Merck, Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10933053B2 (en) 2013-09-09 2021-03-02 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US10420841B2 (en) 2013-03-15 2019-09-24 Merck, Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US11278622B2 (en) 2013-03-15 2022-03-22 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10933053B2 (en) 2013-09-09 2021-03-02 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function

Similar Documents

Publication Publication Date Title
HUS1600008I1 (en) Cephem compounds
AU2003221080A1 (en) Broad-spectrum cephem compounds
AU2003272930A1 (en) Footwere
AU2003902380A0 (en) Cephem compounds
AU2002952355A0 (en) Cephem compounds
AU2003274573A1 (en) Deburrer
AU2003904813A0 (en) Cephem Compounds
AU2003905084A0 (en) Cephem Compounds
AU2003241210A1 (en) Videocomputer
AU2003274754A1 (en) Cephem compounds
AU2003900207A0 (en) New compounds
AU2004903529A0 (en) Cephem Compounds
AU2004903705A0 (en) Cephem Compounds
AU2003901012A0 (en) Novel compounds
AU2003904509A0 (en) Novel Compounds
AU2003904500A0 (en) Novel compounds II
AU2003903928A0 (en) New compounds
AU2003901804A0 (en) New compounds
AU2003100198A4 (en) Colourband Browbands
AU2003100378A4 (en) Scootermansydney
AU2003100006A4 (en) Adcaster
AU2003100325A4 (en) Freez-A-Cube
AU2003100942A4 (en) Energenz
AU2003904501A0 (en) Novel compounds III
AU2003906099A0 (en) Substituted beta-hydroxydiesters